SE8605459D0 - Novel cell growth regulatory factor - Google Patents

Novel cell growth regulatory factor

Info

Publication number
SE8605459D0
SE8605459D0 SE8605459A SE8605459A SE8605459D0 SE 8605459 D0 SE8605459 D0 SE 8605459D0 SE 8605459 A SE8605459 A SE 8605459A SE 8605459 A SE8605459 A SE 8605459A SE 8605459 D0 SE8605459 D0 SE 8605459D0
Authority
SE
Sweden
Prior art keywords
cell lines
cell growth
growth regulatory
human
novel cell
Prior art date
Application number
SE8605459A
Other languages
English (en)
Other versions
SE505059C2 (sv
SE8605459L (sv
Inventor
J M Zarling
M Shoyab
H Marquardt
M B Hanson
M N Lioubin
T J Brown
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of SE8605459D0 publication Critical patent/SE8605459D0/sv
Publication of SE8605459L publication Critical patent/SE8605459L/sv
Publication of SE505059C2 publication Critical patent/SE505059C2/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
SE8605459A 1985-12-20 1986-12-18 Förfarande för celltillväxtreglerande faktorer samt antikroppar reaktiva med dessa SE505059C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81123585A 1985-12-20 1985-12-20
US93528386A 1986-11-26 1986-11-26

Publications (3)

Publication Number Publication Date
SE8605459D0 true SE8605459D0 (sv) 1986-12-18
SE8605459L SE8605459L (sv) 1987-06-21
SE505059C2 SE505059C2 (sv) 1997-06-16

Family

ID=27123452

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605459A SE505059C2 (sv) 1985-12-20 1986-12-18 Förfarande för celltillväxtreglerande faktorer samt antikroppar reaktiva med dessa

Country Status (29)

Country Link
JP (1) JP2559035B2 (sv)
KR (1) KR920005920B1 (sv)
CN (1) CN1017626B (sv)
AT (1) AT400444B (sv)
AU (2) AU601168B2 (sv)
BE (1) BE905957A (sv)
CA (1) CA1340296C (sv)
CH (1) CH675727A5 (sv)
CY (1) CY1608A (sv)
DE (2) DE3643428A1 (sv)
DK (1) DK174094B1 (sv)
ES (1) ES2003180A6 (sv)
FI (1) FI91484C (sv)
FR (1) FR2597108B1 (sv)
GB (1) GB2185485B (sv)
GR (1) GR862936B (sv)
HK (1) HK65691A (sv)
HU (1) HU210694B (sv)
IE (1) IE59415B1 (sv)
IL (1) IL81017A (sv)
IT (1) IT1213428B (sv)
LU (1) LU86718A1 (sv)
NL (1) NL8603209A (sv)
NO (1) NO174556C (sv)
NZ (1) NZ218634A (sv)
OA (1) OA08494A (sv)
PT (1) PT83986B (sv)
SE (1) SE505059C2 (sv)
SG (1) SG60891G (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
US5681930A (en) * 1985-12-20 1997-10-28 Bristol-Myers Squibb Company Anti-oncostatin M monoclonal antibodies
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits
NZ226799A (en) * 1987-11-06 1991-08-27 Oncogen Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor
NO303226B1 (no) * 1990-03-29 1998-06-15 Bristol Myers Squibb Co Monoklonalt antistoff mot Onkostatin M, samt DNA-molekyl, cellelinje og hybridom
IL97622A (en) * 1990-03-29 1997-06-10 Oncogen Limited Partnership Se Monoclonal antibodies that inhibit growth of kaposi's sarcoma
WO1992002556A1 (en) * 1990-08-02 1992-02-20 Michael Valentine Agrez Human colon cancer cell-derived fibroblast elongation factor
IL107040A0 (en) * 1992-09-25 1993-12-28 Lilly Co Eli Modified platelet factor-4

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4645828A (en) * 1984-03-23 1987-02-24 Oncogen Platelet related growth regulator
NZ218634A (en) * 1985-12-20 1991-06-25 Oncogen Peptide identified by its cross reactivity with a cell growth factor, dna, antibodies to peptide and test kits

Also Published As

Publication number Publication date
SE505059C2 (sv) 1997-06-16
NO865178L (no) 1987-06-22
DK615386D0 (da) 1986-12-18
IL81017A0 (en) 1987-03-31
CH675727A5 (sv) 1990-10-31
ES2003180A6 (es) 1988-10-16
KR870005645A (ko) 1987-07-06
IT8622787A0 (it) 1986-12-19
GB8629997D0 (en) 1987-01-28
PT83986A (en) 1987-01-01
GR862936B (en) 1987-10-28
KR920005920B1 (ko) 1992-07-24
FI865156A (sv) 1987-06-21
FI865156A0 (sv) 1986-12-17
CN1017626B (zh) 1992-07-29
FR2597108B1 (fr) 1991-02-15
AU6660886A (en) 1987-06-25
JPS62236498A (ja) 1987-10-16
NO174556B (no) 1994-02-14
IL81017A (en) 1993-01-14
IT1213428B (it) 1989-12-20
IE59415B1 (en) 1994-02-23
AU6776590A (en) 1991-03-14
AT400444B (de) 1995-12-27
OA08494A (fr) 1988-07-29
NZ218634A (en) 1991-06-25
SE8605459L (sv) 1987-06-21
SG60891G (en) 1991-08-23
HUT43103A (en) 1987-09-28
FR2597108A1 (fr) 1987-10-16
CY1608A (en) 1992-04-03
GB2185485A (en) 1987-07-22
JP2559035B2 (ja) 1996-11-27
NL8603209A (nl) 1987-07-16
DE3643428C2 (sv) 1990-08-23
DK174094B1 (da) 2002-06-10
DK615386A (da) 1987-06-21
LU86718A1 (fr) 1988-07-14
BE905957A (fr) 1987-06-17
CA1340296C (en) 1998-12-29
ATA340686A (de) 1995-05-15
DE3643428A1 (de) 1987-09-24
FI91484B (sv) 1994-03-31
HK65691A (en) 1991-08-23
PT83986B (pt) 1989-07-31
CN86108955A (zh) 1987-12-02
HU210694B (en) 1995-06-28
DE3645095C2 (de) 1993-11-18
AU639048B2 (en) 1993-07-15
IE863345L (en) 1987-06-20
NO865178D0 (no) 1986-12-19
NO174556C (no) 1994-05-25
FI91484C (sv) 1994-07-11
AU601168B2 (en) 1990-09-06
GB2185485B (en) 1990-07-04

Similar Documents

Publication Publication Date Title
Schröder et al. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity.
ATE65798T1 (de) Menschlicher granuloxcyt-koloniestimulierungsfaktor.
Hilfiker et al. Biologic properties of chromatographically separated murine thymoma-derived Interleukin 2 and colony-stimulating factor.
GR3022124T3 (en) A yeast cell of the genus schwanniomyces
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
DK163187C (da) Fremgangsmaader til fremstilling af humant immuninterferon (gamma-interferon) samt dna-fragmenter, rekombinante klonings- og udtrykkelsesvektorer og rekombinante mikroorganismer og cellekulturer til anvendelse herved
FI960855A (sv) Monocyt-makrofagcellinjens rekombinantceller för genterapi
ATE153382T1 (de) Rekombinantes dns-verfahren und wirtszellen
MY101972A (en) Primate interleukin - 4
SE9002589D0 (sv) Neutrofil-aktiverande peptid-2
BE887529A (fr) Polypeptide preparer, par voie microbiologique avec sequence d'informations genetiques, microorganismes contenant ces informations genetiques et leur procedes de preparation
ATE93272T1 (de) Expression von protein c.
SE8605459D0 (sv) Novel cell growth regulatory factor
BG60238B1 (bg) Човешки тумор- некротизиращ фактор
Mochizuki et al. Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma.
AU621810B2 (en) Amylolytic enzymes producing microorganisms, constructed by recombinant DNA technology and their use for fermentation processes
JPS6485098A (en) Glycoprotein and production thereof
KR900702009A (ko) 인체 a형 모노아민 옥시다제를 코오딩 하는 dna
Hori et al. Regulation of eosinophil migration by adult T cell leukemia-derived factor.
AU7378087A (en) Interleukin-2 induced antineoplastic peptide
Ulmer et al. Stimulation of colony formation and growth factor production of human T lymphocytes by wheat germ lectin.
ES8700694A1 (es) Un procedimiento para producir un polipeptido de interferon hibrido antivirico y antiproliferante
Oster et al. Gamma-interferon regulates secretion of G-CSF in human monocytes on the transcriptional level
Szabó et al. An inhibitory factor of DNA synthesis derived from the medium of short-time incubated human lymphocytes
CA2051085A1 (en) Expression plasmids

Legal Events

Date Code Title Description
NUG Patent has lapsed